These data suggest that the over-expression of ETV7 could drive breast cancer stem-like cells plasticity through the repression of a panel of IFN-responsive genes, as the treatment with IFN-β, to which most of the validated genes are responsive, could reverse the breast cancer stem cells enrichment. The gene discussed is IFNB1; the disease is breast cancer.